- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.2: 5 residues within 4Å:- Chain A: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.367, A:R.514, A:S.533, A:E.535, A:S.600
CA.3: 5 residues within 4Å:- Chain A: Q.889, D.892, D.895, D.897
- Chain G: N.449
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:Q.889, A:D.892, A:D.895, A:D.897, A:D.897
CA.35: 5 residues within 4Å:- Chain C: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.367, C:R.514, C:S.533, C:E.535, C:S.600
CA.36: 5 residues within 4Å:- Chain A: N.449
- Chain C: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:Q.889, C:D.892, C:D.895, C:D.897, C:D.897
CA.59: 5 residues within 4Å:- Chain E: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.367, E:R.514, E:S.533, E:E.535, E:S.600
CA.60: 5 residues within 4Å:- Chain C: N.449
- Chain E: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:Q.889, E:D.892, E:D.895, E:D.897, E:D.897
CA.83: 5 residues within 4Å:- Chain G: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain G- Metal complexes: G:D.367, G:R.514, G:S.533, G:E.535, G:S.600
CA.84: 5 residues within 4Å:- Chain E: N.449
- Chain G: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain G- Metal complexes: G:Q.889, G:D.892, G:D.895, G:D.897, G:D.897
- 60 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Covalent)(Non-functional Binders)
POV.4: 5 residues within 4Å:- Chain A: L.224, N.225, I.226
- Ligands: POV.5, POV.22
Ligand excluded by PLIPPOV.5: 3 residues within 4Å:- Chain A: R.113, L.118
- Ligands: POV.4
Ligand excluded by PLIPPOV.6: 3 residues within 4Å:- Chain A: L.212
- Chain B: K.16
- Ligands: POV.7
Ligand excluded by PLIPPOV.7: 8 residues within 4Å:- Chain A: T.245, F.306, F.307, M.314, S.317, Y.318
- Chain C: I.323
- Ligands: POV.6
Ligand excluded by PLIPPOV.8: 2 residues within 4Å:- Chain A: M.30, F.33
Ligand excluded by PLIPPOV.9: 3 residues within 4Å:- Chain A: W.23, V.31
- Ligands: CLR.13
Ligand excluded by PLIPPOV.18: 15 residues within 4Å:- Chain A: W.246, T.273, W.275, E.276, V.278
- Chain G: T.298, R.301, L.302, F.306
- Chain H: V.30, F.33, I.34, F.37, C.38
- Ligands: POV.22
Ligand excluded by PLIPPOV.19: 5 residues within 4Å:- Chain A: N.136
- Chain H: F.33, G.36, L.40
- Ligands: POV.20
Ligand excluded by PLIPPOV.20: 3 residues within 4Å:- Chain A: T.149, I.152
- Ligands: POV.19
Ligand excluded by PLIPPOV.21: 8 residues within 4Å:- Chain A: T.229, N.231, S.232
- Chain H: R.19, F.23, I.26
- Ligands: POV.22, POV.98
Ligand excluded by PLIPPOV.22: 11 residues within 4Å:- Chain A: I.226, L.227, K.228, T.229, S.232, V.236, I.243
- Ligands: POV.4, POV.18, POV.21, POV.98
Ligand excluded by PLIPPOV.23: 7 residues within 4Å:- Chain A: R.20, N.265, F.266, Q.267
- Chain B: S.31, D.103, H.105
Ligand excluded by PLIPPOV.24: 4 residues within 4Å:- Chain B: F.23, V.30, I.34, F.35
Ligand excluded by PLIPPOV.25: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPOV.26: 2 residues within 4Å:- Ligands: POV.32, POV.33
Ligand excluded by PLIPPOV.29: 15 residues within 4Å:- Chain A: T.298, R.301, L.302, F.306
- Chain B: V.30, F.33, I.34, F.37, C.38
- Chain C: W.246, T.273, W.275, E.276, V.278
- Ligands: POV.33
Ligand excluded by PLIPPOV.30: 5 residues within 4Å:- Chain B: F.33, G.36, L.40
- Chain C: N.136
- Ligands: POV.31
Ligand excluded by PLIPPOV.31: 3 residues within 4Å:- Chain C: T.149, I.152
- Ligands: POV.30
Ligand excluded by PLIPPOV.32: 8 residues within 4Å:- Chain B: R.19, F.23, I.26
- Chain C: T.229, N.231, S.232
- Ligands: POV.26, POV.33
Ligand excluded by PLIPPOV.33: 11 residues within 4Å:- Chain C: I.226, L.227, K.228, T.229, S.232, V.236, I.243
- Ligands: POV.26, POV.29, POV.32, POV.37
Ligand excluded by PLIPPOV.37: 5 residues within 4Å:- Chain C: L.224, N.225, I.226
- Ligands: POV.33, POV.38
Ligand excluded by PLIPPOV.38: 3 residues within 4Å:- Chain C: R.113, L.118
- Ligands: POV.37
Ligand excluded by PLIPPOV.39: 3 residues within 4Å:- Chain C: L.212
- Chain D: K.16
- Ligands: POV.40
Ligand excluded by PLIPPOV.40: 8 residues within 4Å:- Chain C: T.245, F.306, F.307, M.314, S.317, Y.318
- Chain E: I.323
- Ligands: POV.39
Ligand excluded by PLIPPOV.41: 2 residues within 4Å:- Chain C: M.30, F.33
Ligand excluded by PLIPPOV.42: 3 residues within 4Å:- Chain C: W.23, V.31
- Ligands: CLR.46
Ligand excluded by PLIPPOV.47: 7 residues within 4Å:- Chain C: R.20, N.265, F.266, Q.267
- Chain D: S.31, D.103, H.105
Ligand excluded by PLIPPOV.48: 4 residues within 4Å:- Chain D: F.23, V.30, I.34, F.35
Ligand excluded by PLIPPOV.49: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPOV.50: 2 residues within 4Å:- Ligands: POV.56, POV.57
Ligand excluded by PLIPPOV.53: 15 residues within 4Å:- Chain C: T.298, R.301, L.302, F.306
- Chain D: V.30, F.33, I.34, F.37, C.38
- Chain E: W.246, T.273, W.275, E.276, V.278
- Ligands: POV.57
Ligand excluded by PLIPPOV.54: 5 residues within 4Å:- Chain D: F.33, G.36, L.40
- Chain E: N.136
- Ligands: POV.55
Ligand excluded by PLIPPOV.55: 3 residues within 4Å:- Chain E: T.149, I.152
- Ligands: POV.54
Ligand excluded by PLIPPOV.56: 8 residues within 4Å:- Chain D: R.19, F.23, I.26
- Chain E: T.229, N.231, S.232
- Ligands: POV.50, POV.57
Ligand excluded by PLIPPOV.57: 11 residues within 4Å:- Chain E: I.226, L.227, K.228, T.229, S.232, V.236, I.243
- Ligands: POV.50, POV.53, POV.56, POV.61
Ligand excluded by PLIPPOV.61: 5 residues within 4Å:- Chain E: L.224, N.225, I.226
- Ligands: POV.57, POV.62
Ligand excluded by PLIPPOV.62: 3 residues within 4Å:- Chain E: R.113, L.118
- Ligands: POV.61
Ligand excluded by PLIPPOV.63: 3 residues within 4Å:- Chain E: L.212
- Chain F: K.16
- Ligands: POV.64
Ligand excluded by PLIPPOV.64: 8 residues within 4Å:- Chain E: T.245, F.306, F.307, M.314, S.317, Y.318
- Chain G: I.323
- Ligands: POV.63
Ligand excluded by PLIPPOV.65: 2 residues within 4Å:- Chain E: M.30, F.33
Ligand excluded by PLIPPOV.66: 3 residues within 4Å:- Chain E: W.23, V.31
- Ligands: CLR.70
Ligand excluded by PLIPPOV.71: 7 residues within 4Å:- Chain E: R.20, N.265, F.266, Q.267
- Chain F: S.31, D.103, H.105
Ligand excluded by PLIPPOV.72: 4 residues within 4Å:- Chain F: F.23, V.30, I.34, F.35
Ligand excluded by PLIPPOV.73: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPOV.74: 2 residues within 4Å:- Ligands: POV.80, POV.81
Ligand excluded by PLIPPOV.77: 15 residues within 4Å:- Chain E: T.298, R.301, L.302, F.306
- Chain F: V.30, F.33, I.34, F.37, C.38
- Chain G: W.246, T.273, W.275, E.276, V.278
- Ligands: POV.81
Ligand excluded by PLIPPOV.78: 5 residues within 4Å:- Chain F: F.33, G.36, L.40
- Chain G: N.136
- Ligands: POV.79
Ligand excluded by PLIPPOV.79: 3 residues within 4Å:- Chain G: T.149, I.152
- Ligands: POV.78
Ligand excluded by PLIPPOV.80: 8 residues within 4Å:- Chain F: R.19, F.23, I.26
- Chain G: T.229, N.231, S.232
- Ligands: POV.74, POV.81
Ligand excluded by PLIPPOV.81: 11 residues within 4Å:- Chain G: I.226, L.227, K.228, T.229, S.232, V.236, I.243
- Ligands: POV.74, POV.77, POV.80, POV.85
Ligand excluded by PLIPPOV.85: 5 residues within 4Å:- Chain G: L.224, N.225, I.226
- Ligands: POV.81, POV.86
Ligand excluded by PLIPPOV.86: 3 residues within 4Å:- Chain G: R.113, L.118
- Ligands: POV.85
Ligand excluded by PLIPPOV.87: 3 residues within 4Å:- Chain G: L.212
- Chain H: K.16
- Ligands: POV.88
Ligand excluded by PLIPPOV.88: 8 residues within 4Å:- Chain A: I.323
- Chain G: T.245, F.306, F.307, M.314, S.317, Y.318
- Ligands: POV.87
Ligand excluded by PLIPPOV.89: 2 residues within 4Å:- Chain G: M.30, F.33
Ligand excluded by PLIPPOV.90: 3 residues within 4Å:- Chain G: W.23, V.31
- Ligands: CLR.94
Ligand excluded by PLIPPOV.95: 7 residues within 4Å:- Chain G: R.20, N.265, F.266, Q.267
- Chain H: S.31, D.103, H.105
Ligand excluded by PLIPPOV.96: 4 residues within 4Å:- Chain H: F.23, V.30, I.34, F.35
Ligand excluded by PLIPPOV.97: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPOV.98: 2 residues within 4Å:- Ligands: POV.21, POV.22
Ligand excluded by PLIP- 16 x CLR: CHOLESTEROL(Non-covalent)(Covalent)
CLR.10: 3 residues within 4Å:- Chain A: S.96, V.97, W.100
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.97, A:W.100, A:W.100
CLR.11: 8 residues within 4Å:- Chain A: G.36, I.39, W.43, R.44, F.168, N.172, D.173, K.174
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.39, A:W.43, A:F.168, A:K.174
CLR.12: 7 residues within 4Å:- Chain A: M.21, W.23, A.24, S.28, T.32, Y.198, L.199
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.23, A:T.32, A:Y.198, A:L.199
CLR.13: 4 residues within 4Å:- Chain A: W.23
- Chain B: H.172, W.176
- Ligands: POV.9
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.176
CLR.43: 3 residues within 4Å:- Chain C: S.96, V.97, W.100
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:V.97, C:W.100, C:W.100
CLR.44: 8 residues within 4Å:- Chain C: G.36, I.39, W.43, R.44, F.168, N.172, D.173, K.174
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:I.39, C:W.43, C:F.168, C:K.174
CLR.45: 7 residues within 4Å:- Chain C: M.21, W.23, A.24, S.28, T.32, Y.198, L.199
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.23, C:T.32, C:Y.198, C:L.199
CLR.46: 4 residues within 4Å:- Chain C: W.23
- Chain D: H.172, W.176
- Ligands: POV.42
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:W.176
CLR.67: 3 residues within 4Å:- Chain E: S.96, V.97, W.100
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:V.97, E:W.100, E:W.100
CLR.68: 8 residues within 4Å:- Chain E: G.36, I.39, W.43, R.44, F.168, N.172, D.173, K.174
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:I.39, E:W.43, E:F.168, E:K.174
CLR.69: 7 residues within 4Å:- Chain E: M.21, W.23, A.24, S.28, T.32, Y.198, L.199
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:W.23, E:T.32, E:Y.198, E:L.199
CLR.70: 4 residues within 4Å:- Chain E: W.23
- Chain F: H.172, W.176
- Ligands: POV.66
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:W.176
CLR.91: 3 residues within 4Å:- Chain G: S.96, V.97, W.100
3 PLIP interactions:3 interactions with chain G- Hydrophobic interactions: G:V.97, G:W.100, G:W.100
CLR.92: 8 residues within 4Å:- Chain G: G.36, I.39, W.43, R.44, F.168, N.172, D.173, K.174
4 PLIP interactions:4 interactions with chain G- Hydrophobic interactions: G:I.39, G:W.43, G:F.168, G:K.174
CLR.93: 7 residues within 4Å:- Chain G: M.21, W.23, A.24, S.28, T.32, Y.198, L.199
4 PLIP interactions:4 interactions with chain G- Hydrophobic interactions: G:W.23, G:T.32, G:Y.198, G:L.199
CLR.94: 4 residues within 4Å:- Chain G: W.23
- Chain H: H.172, W.176
- Ligands: POV.90
1 PLIP interactions:1 interactions with chain H- Hydrophobic interactions: H:W.176
- 4 x K: POTASSIUM ION(Non-covalent)
K.14: 9 residues within 4Å:- Chain A: G.289, Y.290
- Chain C: G.289, Y.290
- Chain E: G.289, Y.290
- Chain G: G.289, Y.290
- Ligands: K.15
5 PLIP interactions:1 interactions with chain E, 2 interactions with chain A, 1 interactions with chain C, 1 interactions with chain G- Metal complexes: E:Y.290, A:G.289, A:Y.290, C:Y.290, G:Y.290
K.15: 10 residues within 4Å:- Chain A: V.288, G.289
- Chain C: V.288, G.289
- Chain E: V.288, G.289
- Chain G: V.288, G.289
- Ligands: K.14, K.16
5 PLIP interactions:1 interactions with chain A, 2 interactions with chain E, 1 interactions with chain C, 1 interactions with chain G- Metal complexes: A:G.289, E:V.288, E:G.289, C:G.289, G:G.289
K.16: 10 residues within 4Å:- Chain A: T.287, V.288
- Chain C: T.287, V.288
- Chain E: T.287, V.288
- Chain G: T.287, V.288
- Ligands: K.15, K.17
5 PLIP interactions:1 interactions with chain A, 2 interactions with chain G, 2 interactions with chain C- Metal complexes: A:V.288, G:T.287, G:V.288, C:T.287, C:V.288
K.17: 5 residues within 4Å:- Chain A: T.287
- Chain C: T.287
- Chain E: T.287
- Chain G: T.287
- Ligands: K.16
4 PLIP interactions:1 interactions with chain A, 1 interactions with chain E, 1 interactions with chain G, 1 interactions with chain C- Metal complexes: A:T.287, E:T.287, G:T.287, C:T.287
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.27: 1 residues within 4Å:- Chain B: N.53
No protein-ligand interaction detected (PLIP)NAG.28: 4 residues within 4Å:- Chain B: T.55, N.90, N.91, N.95
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.55, B:N.95
NAG.51: 1 residues within 4Å:- Chain D: N.53
No protein-ligand interaction detected (PLIP)NAG.52: 4 residues within 4Å:- Chain D: T.55, N.90, N.91, N.95
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:T.55, D:N.95
NAG.75: 1 residues within 4Å:- Chain F: N.53
No protein-ligand interaction detected (PLIP)NAG.76: 4 residues within 4Å:- Chain F: T.55, N.90, N.91, N.95
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:T.55, F:N.95
NAG.99: 1 residues within 4Å:- Chain H: N.53
No protein-ligand interaction detected (PLIP)NAG.100: 4 residues within 4Å:- Chain H: T.55, N.90, N.91, N.95
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:T.55, H:N.95
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tao, X. et al., Molecular structures of the human Slo1 K + channel in complex with beta 4. Elife (2019)
- Release Date
- 2019-12-25
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ACEG
Calcium-activated potassium channel subunit beta-4: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BE
CG
DB
ED
FF
GH
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
- 60 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Covalent)(Non-functional Binders)
- 16 x CLR: CHOLESTEROL(Non-covalent)(Covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tao, X. et al., Molecular structures of the human Slo1 K + channel in complex with beta 4. Elife (2019)
- Release Date
- 2019-12-25
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ACEG
Calcium-activated potassium channel subunit beta-4: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BE
CG
DB
ED
FF
GH
H - Membrane
-
We predict this structure to be a membrane protein.